ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 101 filers reported holding ENDOLOGIX INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $575,000 | -62.9% | 800,477 | -1.2% | 0.02% | -52.1% |
| Q3 2018 | $1,548,000 | -93.7% | 810,461 | -81.3% | 0.05% | -94.2% |
| Q2 2018 | $24,487,000 | -2.3% | 4,326,389 | -27.0% | 0.83% | -14.0% |
| Q1 2018 | $25,055,000 | -21.0% | 5,923,161 | -0.1% | 0.97% | -29.8% |
| Q4 2017 | $31,715,000 | +8.7% | 5,928,101 | -9.4% | 1.38% | -4.2% |
| Q3 2017 | $29,189,000 | -5.7% | 6,544,676 | +2.8% | 1.44% | -23.6% |
| Q2 2017 | $30,950,000 | +57.3% | 6,368,299 | +134.4% | 1.88% | +47.5% |
| Q1 2017 | $19,674,000 | +185.0% | 2,717,394 | +125.2% | 1.28% | +114.6% |
| Q4 2016 | $6,903,000 | -84.5% | 1,206,894 | -65.3% | 0.60% | -83.2% |
| Q3 2016 | $44,552,000 | -9.8% | 3,480,644 | -12.2% | 3.54% | -24.9% |
| Q2 2016 | $49,376,000 | +139.2% | 3,962,753 | +60.5% | 4.72% | +123.3% |
| Q1 2016 | $20,640,000 | +107.0% | 2,468,847 | +145.1% | 2.11% | +183.1% |
| Q4 2015 | $9,971,000 | -2.6% | 1,007,177 | +26.7% | 0.75% | -39.0% |
| Q1 2014 | $10,233,000 | +85.9% | 795,095 | +151.8% | 1.22% | +80.0% |
| Q4 2013 | $5,506,000 | – | 315,733 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|